A new study reports that 16.5% of sarcoidosis patients experience EDS (excessive daytime sleepiness),  16.4% experience severe fatigue, and 6.3% of patients report both symptoms. The study titled, “Fatigue and Excessive Daytime Sleepiness in Sarcoidosis: Prevalence, Predictors, and Relationships between the Two Symptoms,” was published in the journal…

Researchers working in sarcoidosis may submit project proposals to the American Thoracic Society (ATS) Foundation/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis, which will award one $80,000 grant ($40,000 a year for two years) to a principal investigator who is conducting research in this disease. The two-year grant starts in…

A new report discussing the case of a cardiac sarcoidosis patient with bidirectional ventricular tachycardia (BVT) provides additional information to help improve diagnoses in these patients. The study, “Bidirectional ventricular tachycardia in cardiac sarcoidosis,” was published in the Journal of Arrhythmia. Cardiac sarcoidosis involves myocardial inflammation and…

A new study examined the case of a 30-year-old man who developed sarcoidosis in the lungs after treatment with infliximab (sold as Remicade, Inflectra) for his Crohn’s disease, a chronic condition affecting the gastrointestinal tract. The case study, titled “Pulmonary Sarcoidosis That Developed During the Treatment of a Patient…

African-American women face a higher risk than any other ethnic group of developing sarcoidosis, says the American Osteopathic Association (AOA), noting in a new report that the once-rare fibrotic disease now affects an estimated 200,000 Americans. Sarcoidosis, which can be difficult to diagnose because of its varied symptoms, affects one or more…

Anti-TNF agents such as AbbVie’s Humira (adalimumab) or Janssen’s Remicade (infliximab), were found to be effective in treating cutaneous sarcoidosis, according to a French study of 46 cases. The study, “Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis, A French Study…

Sarcoidosis may appear in cancer patients who respond well to treatment with dendritic cell-based vaccines, according to a case series report from Germany. At the Friedrich-Alexander-University Erlangen-Nürnberg and the associated Erlangen University Hospital, researchers noted three patients with malignant melanoma who developed sarcoidosis after or during such treatment.

A rare case report of a woman with sarcoidosis in the liver and spleen, who developed signs of inflammatory bowel disease (IBD) during recovery, illustrates that sarcoidosis can occur in less than typical ways. The study by researchers at the University of Bari Aldo Moro in Italy, titled “A…

A recent case report supports the theory that inhibiting a molecular pathway called programmed cell death-1 (PD-1) may involve processes that lead to sarcoidosis in some cancer patients. The study, “Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma,” was published in the journal JAAD Case Reports. Sarcoidosis, as well…

Increased levels of a specific type of T-cell in some patients with melanoma might explain the connection between the cancer and sarcoidosis, researchers suggest in a study that explored melanoma patients treated with immunotherapy. The study, “Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and…